Bryant McLaughlin

Bispecific Antibodies Unleashed

Sponsored Content

Bispecific Antibodies Unleashed Bispecific Antibodies Unleashed

Working Toward an AAV Platform: Challenges, Threats, and Opportunities

Nov 2, 2023

1 Min Read

Sponsored Content

Working Toward an AAV Platform: Challenges, Threats, and Opportunities Working Toward an AAV Platform: Challenges, Threats, and Opportunities

byMégane Denu, Quentin Bazotand 1 more

Oct 20, 2023

Downstream

Recent in Downstream

A Scalable Single-Use Two-Step Plasmid Purification Process

Sponsored Content

A Scalable Single-Use Two-Step Plasmid Purification Process A Scalable Single-Use Two-Step Plasmid Purification Process

Minimizing Lentiviral Vector Loss During the Purification Process Using an Innovative Nanofiber Adsorbent

Nov 3, 2023

20 Min View

Sponsored Content

Minimizing Lentiviral Vector Loss During the Purification Process Using an Innovative Nanofiber Adsorbent Minimizing Lentiviral Vector Loss During the Purification Process Using an Innovative Nanofiber Adsorbent

Oct 31, 2023

20 Min View

Manufacturing

Recent in Manufacturing

Breyanzi: BMS seeking to expand outreach of lymphoma therapy Breyanzi: BMS seeking to expand outreach of lymphoma therapy

byJosh Abbott

Aug 22, 2024

3 Min Read

Fujifilm expands UK manufacturing space with one eye on the future Fujifilm expands UK manufacturing space with one eye on the future

byJosh Abbott

Aug 22, 2024

2 Min Read

Analytical

Recent in Analytical

The Key Role of Analytical Methods in Technology Transfer

Sponsored Content

The Key Role of Analytical Methods in Technology Transfer The Key Role of Analytical Methods in Technology Transfer

byOlena Chervonenko

Oct 17, 2023

Measurement of Particulates in Single-Use Systems for Cell and Gene Therapies Manufacturing — Part 1: Misapplication of USP <788>

Cell Line Development

Measurement of Particulates in Single-Use Systems for Cell and Gene Therapies Manufacturing — Part 1: Misapplication of USP <788>Measurement of Particulates in Single-Use Systems for Cell and Gene Therapies Manufacturing — Part 1: Misapplication of USP <788>

byJames D. Vogel, Andreas Hohenleutnerand 2 more

Jun 26, 2023

Business

Recent in Business

Key strategies for effective technology evaluation Key strategies for effective technology evaluation

byKim Bennett

Aug 8, 2024

2 Min Read

Resilience logo

Sponsored Content

Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience

Jun 25, 2024

15 Min View

Therapeutic Modalities

Recent in Therapeutic Modalities

Biomanufacturing in space accelerating therapy development on Earth Biomanufacturing in space accelerating therapy development on Earth

byJosh Abbott

Jul 24, 2024

3 Min Read

DNA Synthesis: Chemical, Enzymatic, or Both?

Therapeutic Modalities

DNA Synthesis: Chemical, Enzymatic, or Both?DNA Synthesis: Chemical, Enzymatic, or Both?

byMark Behlke

Oct 20, 2023

BioProcess Insider

Recent in BioProcess Insider

Upstream & Downstream Processing

Bioprocessing Q3: After 18 challenging months, is the worst behind?Bioprocessing Q3: After 18 challenging months, is the worst behind?

byDan Stanton

Oct 24, 2024

4 Min Read

How and why AstraZeneca’s oncology eyes turned to cell therapies How and why AstraZeneca’s oncology eyes turned to cell therapies

Therapeutic Class

byDan Stanton

Oct 18, 2024

4 Min Read

Home
Bryant McLaughlin

Bryant McLaughlin

Latest from Bryant McLaughlin

Alphalyse supplier side

Sponsored Content

Beyond ELISA: Is Mass Spectrometry the Future of Impurity Analysis?Beyond ELISA: Is Mass Spectrometry the Future of Impurity Analysis?

byThomas Kofoed, Margarita Sabaterand 2 more

Oct 15, 2024

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

Ask the Expert webcasts

ATE Webcasts

Ask the Expert webcasts

ATE Webcasts

BPI Podcasts

Voices of Biotech

Podcast: Sustainability is about health equity, says ScaleReady and Germfree

ScaleReady and Germfree discuss the need to rethink sustainability and move towards a more standardized and simplistic manufacturing model to ensure health equity can be achieved.

Insider News

Rentschler bolsters production with 3,400 square-meter expansion
Oct 25, 2024
|
2 Min Read
GSK to invest up to $800m in Pennsylvania site expansion
Oct 24, 2024
|
2 Min Read
Bioprocessing Q3: After 18 challenging months, is the worst behind?
Oct 24, 2024
|
4 Min Read
Ins & Outs: Forge, Veranova, Cellipont announce C-suite rejigs
Oct 24, 2024
|
3 Min Read